Abstract
Backgrounds
Gamma-glutamyltransferase (GGT) is an enzyme responsible for the extracellular catabolism of the antioxidant glutathione and recently implicated in the pathogenesis of atherosclerosis. Endothelial dysfunction is a prodromal feature of atherogenesis. Since oxidative stress is highly present in uremia and causally linked to endothelial dysfunction, we hypothesized that GGT may be a factor implicated in this process.
Methods
Serum GGT and C-reactive protein (CRP) levels, estimated glomerular filtration rate (eGFR), and 24-h proteinuria were measured in 214 nondiabetic stages 3–5 CKD patients. The endothelium-dependent vasodilatation (FMD) of the brachial artery was assessed by using high-resolution ultrasound. We investigated the relationship between FMD and circulating serum GGT.
Results
Serum GGT levels were negatively associated with FMD (r = −0.41, p < 0.001) and eGFR (r = −0.34, p < 0.001) in univariate analysis. Multivariate regression analysis showed that the association between GGT and FMD persisted after adjustment for age, sex, smoking, renal function (eGFR), inflammation (CRP), proteinuria, and homeostatic model assessment index.
Conclusion
Circulating GGT levels significantly associate with endothelial dysfunction, an important early feature of the atherogenic process. GGT might be an early marker of oxidative or other cellular stress that it is possibly directly related to the pathogenesis of endothelial dysfunction.
Similar content being viewed by others
References
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–2047
Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126
Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C (2006) The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47:42–50
Sahin EBF, Karaman M, Ay AS, Saglam M, Cakir E, Yilmaz MI (2010) The relationship between endothelial dysfunction and pentraxin-3 concentration in chronic kidney disease. Turk Nephrol Dial Transpl 19:192–198
Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G (2001) Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104:191–196
Zoccali C (2006) Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 17(Suppl 2):S61–S63
Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38:263–355
Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M (1998) Gamma-glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 25:786–792
Dominici S, Valentini M, Maellaro E, Del Bello B, Paolicchi A, Lorenzini E, Tongiani R, Comporti M, Pompella A (1999) Redox modulation of cell surface protein thiols in U937 lymphoma cells: the role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation. Free Radic Biol Med 27:623–635
Lee DH, Blomhoff R, Jacobs DR (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535–539
Caliskan M, Erdogan D, Gullu H, Ciftci O, Yildirim I, Baycan S, Yildirir A, Muderrisoglu H (2007) Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens 25:2497–2503
Caliskan M, Erdogan D, Gullu H, Muderrisoglu H (2008) Higher serum gamma-glutamyltransferase levels are independently associated with impaired coronary microvascular function in patients with dilated cardiomyopathy. Atherosclerosis 201:163–167
Emdin M, Pompella A, Paolicchi A (2005) Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112:2078–2080
Emdin M, Passino C, Michelassi C, Titta F, L’abbate A, Donato L, Pompella A, Paolicchi A (2001) Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 22:1802–1807
Meisinger C, Döring A, Schneider A, Löwel H, Group KS (2006) Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189:297–302
Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H (2005) Group VHMaPPS. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130–2137
Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J (2006) Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 27:2170–2176
Perry IJ, Wannamethee SG, Shaper AG (1998) Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 21:732–737
Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M (2003) Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49:1358–1366
Wannamethee SG, Shaper AG, Lennon L, Whincup PH (2005) Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 28:2913–2918
Lee DH, Jacobs DR, Gross M, Steffes M (2005) Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 51:1185–1191
Ryu S, Chang Y, Kim DI, Kim WS, Suh BS (2007) Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 53:71–77
Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M (2008) Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 19:1564–1570
Postorino M, Marino C, Tripepi G, Zoccali C (2008) Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. Kidney Int Suppl 111:S64–S66
Targher G (2010) Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer—a narrative review. Clin Chem Lab Med 48:147–157
Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM (2002) The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62:1524–1538
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115
Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, Glauber M, Pompella A, Paolicchi A (2009) Gamma-glutamyltransferase activity in human atherosclerotic plaques–biochemical similarities with the circulating enzyme. Atherosclerosis 202:119–127
Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A (2006) Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 186:80–85
Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M (2006) Gamma-glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses 67:1060–1064
Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis. Diabetes Care 32:741–750
Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA (2007) Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women’s Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 27:2729–2735
Lee DH, Steffes MW, Jacobs DR (2008) Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia 51:402–407
Lee DH, Jacobs DR (2009) Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants? Free Radic Res 43:533–537
Daeppen JB, Smith TL, Schuckit MA (1998) Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 22:941–944
Nilssen O, Førde OH, Brenn T (1990) The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 132:318–326
Diercks GF, van Boven AJ, Hillege JL, de Jong PE, Rouleau JL, van Gilst WH (2002) The importance of microalbuminuria as a cardiovascular risk indicator: a review. Can J Cardiol 18:525–535
Franzini M, Ottaviano V, Fierabracci V, Bramanti E, Zyw L, Barsacchi R, Scatena F, Boni C, Mammini C, Passino C, Pompella A, Emdin M, Paolicchi A (2008) Fractions of plasma gamma-glutamyltransferase in healthy individuals: reference values. Clin Chim Acta 395:188–189
Acknowledgments
We thank the patients and personnel involved in the creation of this patient material. The authors would like to express their sincere appreciation to FAVOR (FMF Arthritis Vasculitis and Orphan Diseases Research/www.favor.org.tr) web registries at Gulhane Military Medical Academy, Institute of Health Sciences for their supports in epidemiological and statistical advisory and invaluable guidance for the preparation of the manuscript. We acknowledge support from the Gülhane School of Medicine in Turkey, the Swedish Research Council, and the Loo and Hans Osterman Foundation.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yilmaz, M.I., Turgut, F., Kanbay, M. et al. Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease. Int Urol Nephrol 45, 1071–1078 (2013). https://doi.org/10.1007/s11255-012-0354-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-012-0354-2